01 November 2005
Clinical Spectrum and Critical Care Management of Posterior Reversible Encephalopathy Syndrome (PRES).
Pasquale Striano, Salvatore Striano, Fabio Tortora, Edoardo De Robertis, Daniela Palumbo, Andrea Elefante, Giuseppe ServilloMed Sci Monit 2005; 11(11): CR549-553 :: ID: 430371
Abstract
Background: Posterior Reversible Encephalopathy (PRES) is characterizedby acute-onset headache, altered mental status, cortical blindness and seizures, with parietal-occipitalinvolvement. We report all cases of PRES diagnosed in our intensive care unit during the last 4 years,and evaluate their outcome in terms of the different medical treatments used. Even if usually reversible,PRES can sometimes result in death or irreversible neurological deficit, such as chronic epilepsy. Material/Methods:From January 2001 to January 2005, we identified 8 female patients with PRES. All patients underwentbasal and follow-up brain MRI. Patients referred to Epilepsy Center (about 3000 patients) were reviewedin order to identify subjects with a clinical history of PRES. These latter were clinically re-evaluatedand underwent video-EEG, MRI study and neuropsychological testing. Results: Of the 8 patients, 5 hadhypertensive encephalopathy during pregnancy; 2 had eclampsia during the postpartum period; 1 patientwith chronic renal failure developed symptoms after immunosuppressive treatment. In all patients but1, neurological and radiological abnormalities resolved after appropriate treatment. In addition, wefound 2 patients with temporal lobe epilepsy subsequent to a previous PRES. MRI revealed cortical-subcorticalmalacia in the parietal-occipital regions. Conclusions: The widespread use of MRI technology has madePRES familiar to many clinicians. Although PRES is reversible when treatment is instituted, delayed diagnosisand therapy can result in chronic neurological sequelae. The relationship between hypertensive encephalopathyand chronic epilepsy needs to be confirmed by longitudinal studies. Normalization of blood pressure andtreatment of seizures deserves particular attention.
Keywords: Brain Diseases - therapy, Blindness, Cortical - diagnosis, Electroencephalography, Epilepsy - therapy, Headache - therapy, Hypertensive Encephalopathy - therapy, Intensive Care, Magnetic Resonance Imaging, Mental Disorders - therapy, Seizures - therapy, Syndrome
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952